CARD9 S12N RISK ALLELE

Clinical trials for CARD9 S12N RISK ALLELE explained in plain language.

Never miss a new study

Get alerted when new CARD9 S12N RISK ALLELE trials appear

Sign up with your email to follow new studies for CARD9 S12N RISK ALLELE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Fungal fighter fails to finish Crohn's trial

Disease control Terminated

This study tested whether an oral antifungal medication called posaconazole could help control active Crohn's disease. It specifically enrolled 10 adult patients who had both active Crohn's and a particular genetic marker thought to make them sensitive to a common skin fungus. Th…

Matched conditions: CARD9 S12N RISK ALLELE

Phase: PHASE4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

CARD9 S12N RISK ALLELE

Get alerted when new CARD9 S12N RISK ALLELE trials appear

Fungal fighter fails to finish Crohn's trial